RxDoctor Payments Data

Fred Foshee, DO

Family Medicine · Maryville, TNNPI 1245421668

Payments from drug & device makers

$2,743in general payments, 2019–2025

Across 175 payments — averaging $15.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$729
  • Pfizer$529
  • AbbVie$221
  • GSK$203
  • Lilly USA, LLC$197
  • AstraZeneca$181
  • plus $684 from 15 others

What the payments were for

  • Food & beverage$2,71199%
  • Education$321%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,743 in reported general payments places this provider in the 70th percentile of 2,087 family medicine providers in Tennessee.

See all family medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$81,417
Medicare patients
167
Services billed
614

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban144$137,105
OzempicSemaglutide47$71,899
XareltoRivaroxaban33$40,838
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl402$32,553
JardianceEmpagliflozin27$32,242
Trelegy ElliptaFluticasone/Umeclidin/Vilanter37$27,759
SuboxoneBuprenorphine Hcl/Naloxone Hcl52$24,301
JanuviaSitagliptin Phosphate12$19,807
MounjaroTirzepatide12$17,042
SymbicortBudesonide/Formoterol Fumarate36$13,929
LinzessLinaclotide22$13,901
MyrbetriqMirabegron11$11,776
VascepaIcosapent Ethyl17$8,975
Incruse ElliptaUmeclidinium Bromide15$7,507
Combivent RespimatIpratropium/Albuterol Sulfate11$6,353

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$529$137,105144 claims
Novo NordiskOzempic$729$71,89947 claims
Johnson & JohnsonXarelto$90$40,83833 claims
Boehringer IngelheimJardiance, Combivent Respimat$63$38,59538 claims
GSKTrelegy Ellipta, Incruse Ellipta$203$35,26652 claims
Lilly USA, LLCMounjaro$197$17,04212 claims
AstraZenecaSymbicort$181$13,92936 claims
AbbVieLinzess$221$13,90122 claims
Astellas Pharma US IncMyrbetriq$48$11,77611 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,087 family medicine providers in Tennessee.

Other family medicine in Maryville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →